Repeated treatment with antibody-targeted superantigens strongly inhibits tumor growth

International Journal of Cancer

Volumn 76, Issue 2, 1998, Pages 274-283

  Rosendahl, Alexander ^a,b   Kristensson', Karin ^a,b   Hansson, Johan ^a,b   Ohlsson, Lennart ^a,b   Kalland, Terje ^a,b   Dohlsten, Mikael ^a,b  

^a Pharmacia & Upjohn AB   (Sweden)

^b LUND UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER ANTIBODY; GAMMA INTERFERON; IMMUNOGLOBULIN F(AB) FRAGMENT; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 6; MONOCLONAL ANTIBODY; STAPHYLOCOCCUS ENTEROTOXIN A; SUPERANTIGEN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER IMMUNOTHERAPY; CANCER INHIBITION; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; HELPER CELL; IMMUNOHISTOCHEMISTRY; INTRAVENOUS DRUG ADMINISTRATION; LUNG METASTASIS; MELANOMA; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION;

ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL DIVISION; CYTOKINES; DRUG ADMINISTRATION SCHEDULE; ENTEROTOXINS; FEMALE; IMMUNOGLOBULIN FRAGMENTS; IMMUNOTOXINS; INTERFERON INDUCERS; INTERFERON TYPE II; LUNG NEOPLASMS; LYMPHOMA, B-CELL; MELANOMA, EXPERIMENTAL; MICE; MICE, INBRED C57BL; SUPERANTIGENS; T-LYMPHOCYTES, CYTOTOXIC; TIME FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0032513527     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19980413)76:2<274::AID-IJC16>3.0.CO;2-C     Document Type: Article

References (38)

1. ABRAHMSEN, L., DOHLSTEN, M., SEGREN, S., BJORK, P., JONSSON, E. and KALLAND, T., Characterization of two distinct MHC class II binding sites in the superantigen staphylococcal enterotoxin A. EMBO J., 14, 2978-2986 (1995).
2. BELFRAGE, H., DOHLSTEN, M., HEDLUND, G. and KALLAND, T., Prevention of superantigen-induced down-regulation of T-cell mediated cytotoxic activity by IL-2 in vivo. Immunology, 90,183-188 (1997a).
3. BELFRAGE, H., DOHLSTEN, M., HEDLUND, G. and KALLAND, T., Prevention of superantigen-induced tolerance m vivo by interleukin-2 treatment. Cancer Immimol. Immunother., 44,77-82 (1997b).
4. CARLSSON, R. and SJOGREN, H.O., Kinetics of IL-2 and interferon-gamma production, expression of IL-2 receptors, and cell proliferation in human mononuclear cells exposed to staphylococcal enterotoxin A. Cell Immimol., 96, 175-183 (1985).
5. DE WAAL MALEFYT, R., ABRAMS, J., BENNETT, B., FIGDOR, C.G. and DE VRIES, J.E., Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J. exp. Med., 174, 1209-1220 (1991a).
6. DE WAAL MALEFYT, R., HAANEN, J., Spits, H., RONCAROLO, M.G., TE VELDE, A., FIGDOR, C., JOHNSON, K., KASTELEIN, R., YSSEL, H. and DE VRIES, J.E., Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression. J. exp. Med., 174,915-924 (1991b).
7. + T cell clones and resting T cells. Specific inhibition of IL-2 production and proliferation. J. Immimol., 150, 4754-4765 (1993).
8. DOHLSTEN, M., ABRAHMSEN, L., BJORK, P., LANDO, P.A., HEDLUND, G., FORSBERG, G., BRODIN, T., GASCOIGNE, N.R., FORBERG, C., LIND, P. and KALLAND, D.T., Monoclonal antibody-superantigen fusion proteins: tumorspecific agents for T-cell-based tumor therapy. Proc. nat. Acad. Sci. (Wash.), 91, 8945-8949 (1994).
9. DOHLSTEN, M., BJORKLUND, M., SUNDSTEDT, A., HEDLUND, G., SAMSON, D. and KALLAND, T., Immunopharmacology of the superantigen staphylococcal enterotoxin A in T-cell receptor V beta 3 transgenic mice. Immunology, 79, 520-527 (1993).
10. DOHLSTEN, M., HANSSON, J., OHLSSON, L., LITTON, M. and KALLAND, T., Antibody-targeted superantigens are potent inducers of tumor-infiltratinc T lymphocytes in vivo. Proc. nat. Acad. Sci. (Wash.), 92, 9791-9795 (1995).
11. DOHLSTEN, M., HEDLUND, G., AKERBLOM, E., LANDO, P.A. and KALLAND, T., Monoclonal antibody-targeted superantigens: a different class of anti-tumor agents. Proc. nat. Acad. Sci. (Wash.), 88, 9287-9291 (1991).
12. DOHLSTEN, M., LANDO, P.A., HEDLUND, G., TROWSDALE, J. and KALLAND, T., Targeting of human cytotoxic T lymphocytes to MHC class IIexpressing cells by staphylococcal enterotoxins. Immunology, 71, 96-100 (1990).
13. FISCHER, H., DOHLSTEN, M., ANDERSSON, U., HEDLUND, G., ERICSSON, P., HANSSON, J. and SJOGREN, H.O., Production of TNF-alpha and TNF-beta by staphylococcal enterotoxin A activated human T cells. J. Immimol., 144, 4663-4669 (1990).
14. FLORES VILLANUEVA, P.O., REISER, H. and STADECKER, M.J., Regulation of T helper cell responses in experimental murine schistosomiasis by IL-10. Effect on expression of B7 and B7-2 costimulatory molecules by macrophages. J. Immimol, 153,5190-5199 (1994).
15. FRASER, J.D., High-affinity binding of staphylococcal enterotoxins A and B to HLA-DR. Nature (Lond.), 339, 221-223 (1989).
16. GIANTONIO, B.J. and 14 OTHERS, Superantigen-based immunotherapy: a phase I trial of PNU-214565, a monoclonal antibody-staphylococcal enterotoxin A recombinant fusion protein, in advanced pancreatic and colorectal cancer. J. din. Oncol, 15, 1994-2007 (1997).
17. HENKART, M.P. and HENKART, P.A., Lymphocyte mediated cytolysis as a secretory phenomenon. Adv. Exp. Med. Biol., 146, 227-247 (1982).
18. + cells to bacterial superantigens. Europ. J. Immimol., 22, 1935-1938 (1992).
19. JAIN, R.K., Transport of molecules in the tumor interstitium: a review. Cancer Res., 47, 3039-3051 (1987).
20. KAPPLER, J.W., STAERZ, U., WHITE, J. and MARRACK, P.C., Self-tolerance eliminates T cells specific for Mis-modified products of the major histocompatibility complex. Nature (Land.), 332, 35-40 (1988).
21. + T cells in mice tolerant to Staphylococcus aurais enterotoxin B [see comments]. Nature (Lond.), 349, 245-248 (1991).
22. LITTON, M.J., DOIILSTEN, M., HANSSON, J., ROSENDAIIL, A., OHLSSON, L., KALLAND, T., ANDERSSON, J. and ANDERSSON, U., Tumor therapy with an antibody-targeted superantigen generates divergent local and systemic immune responses. Am. J. Pathol., 150, 1607-1618 (1997).
23. MAREEL, M., DRAGONETTI, C., TA VERNIER, J. and FIERS, W., Tumor-selective cytotoxic effects of murine tumor necrosis factor (TNF) and interferongamma (IFN-gamma) in organ culture of B16 melanoma cells and heart tissue. Int. J. Cancer, 42, 470-473 (1988).
24. MARRACK, P. and KAPPLER, J., The staphylococcal enterotoxins and their relatives [published erratum appears in Science, 1990 Jun 1;248(4959): 1066] [see comments].
25. Science, 248, 705-711 (1990).
26. MASSON, D. and TSCHOPP, J., Isolation of a lytic, pore-forming protein (perform) from cytolytic T-lymphocytes. J. biol, Cliem., 260, 9069-9072 (1985).
27. MOR, F. and COHEN, I.R., IL-2 rescues antigen-specific T cells from radiation or dexamethasone-induced apoptosis. Correlation with induction of Bcl-2. J. Immimol, 156, 515-522 (1996).
28. PODACK, E.R., YOUNG, J.D. and COHN, Z.A., Isolation and biochemical and functional characterization of perform 1 from cytolytic T-cell granules. Proc. nat. Acad. Sci. (Wash.), 82, 8629-8633 (1985).
29. RIETHMULLER, G. and JOHNSON, J.P., Monoclonal antibodies in the detection and therapy of micrometastatic epithelial cancers. Curr. Opin. Immimol., 4, 647-655 (1992).
30. ROSENDAHL, A., HANSSON, J., SUNDSTEDT, A., KALLAND, T. and DOHLSTEN, M., Immune response during tumor therapy with antibody-superantigen fusion proteins. Int. J. Cancer, 68, 109-113 (1996).
31. SUNDSTEDT, A., DOHLSTEN, M., HEDLUND, G., HOIDEN, L., BjORKLUND, M. and KALLAND, T., Superantigens anergize cytokine production but not cytotoxicity in vivo [published erratum appears in Immunology 1994 Jul;82(3):504].
32. Immunology, 82, 117-125 (1994).
33. + T cells. J. Immimol., 154, 6306-6313 (1995).
34. + T cells express perturbed AP-1 and NF-kappa B transcription factors. Proc. not. Acad. Sci. (Wash.), 93, 979-984 (1996).
35. TAGA, K. and TOSATO, G., IL-10 inhibits human T cell proliferation and IL-2 production. J. Immunol. 148, 1143-1148 (1992).
36. WAHL, C, MIETHKE, T., HEEG, K. and WAGNER, H., Clonal deletion as direct consequence of an in vivo T cell response to bacterial superantigen. Europ. J. Immunol., 23, 1197-1200 (1993).
37. WHITE, J., HERMAN, A., PULLEN, A.M., KUBO, R., KAPPLER, J.W. and MARRACK, P., The V beta-specific superantigen staphylococcal enterotoxin B: stimulation of mature T cells and clonal deletion in neonatal mice. Cell, 56, 27-35 (1989).
38. WILLEMS, F., MARCHANT, A., DELVILLE, J.P., GERARD, C., DELVAUX, A., VELU, T., DE BOER, M. and GOLDMAN, M., Interleukin-10 inhibits B7 and intercellular adhesion molecule-1 expression on human monocytes. Europ. J. Immunol., 24, 1007-1009 (1994).